Prenetics Global Sees FY2026 Sales $220.000M-$230.000M vs $214.071M Est

B. Riley Securities Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $37

B. Riley Securities analyst Jeff Van Sinderen initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy rating and announces Price Target of $37.

Prenetics Global shares are trading higher after a Form 4 filing showed IM8’s CFO bought 23,100 shares at an average price of $21.55 each.

Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results

Prenetics Global Limited (NASDAQ: PRE) announced that CEO Danny Yeung and CFO Brian Rosin purchased $1.0 million in company shares during August 2026, bringing cumulative leadership investment to $3.75 million since November 2025. The purchases follow strong Q2 2026 results with total revenue up 288% YoY to $46.5 million, IM8 revenue reaching $45.0 million (up 359% YoY), and the company achieving its first month of positive consolidated Adjusted Free Cash Flow in July. Prenetics raised FY 2026 revenue guidance to $220-230 million and introduced FY 2027 guidance of over $400 million.

Prenetics Global CEO Danny Yeung And CFO Brian Rosin Acquire Total Of $1M Worth Of Shares In Open Market Purchases

Danny Yeung, Chief Executive OfficerPurchased 24,681 shares for approximately $502,000, at an average price of roughly $20.34 per share, across purchases on August 20 and August 24, 2026. This brings his cumulative